세계의 혈청 분리 젤 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 최종 사용자별, 지역별 전망 및 예측(2024-2031년)

The Global Serum Separation Gel Market size is expected to reach $13.3 billion by 2031, rising at a market growth of 6.7% CAGR during the forecast period.

North America has a significant aging population, with a growing number of older adults experiencing age-related chronic conditions and comorbidities. There is an increasing emphasis on preventive healthcare and early disease detection in North America, driven by efforts to reduce healthcare costs, improve patient outcomes, and promote population health. Therefore, the North America region generated $2,756.6 million revenue in 2023. The region's advanced healthcare system fosters the adoption of innovative medical technologies, including serum separation gel, to support diagnostic testing, biomedical research, and therapeutic development.

Higher healthcare spending improves access to advanced healthcare services, including diagnostic testing and specialized medical treatments. Serum separation gel is essential for obtaining serum samples used in diagnostic tests for various diseases and health conditions. Increased access to healthcare services drives the demand for serum separation gel products in clinical settings. Therefore, the market is expanding significantly due to the integration of healthcare expenditure.

Additionally, Veterinary medicine has seen significant advancements in recent years, including improved diagnostic technologies and treatment modalities. As veterinary practices adopt advanced diagnostic techniques such as immunoassays, molecular diagnostics, and point-of-care testing, the demand for high-quality serum samples obtained with serum separation gel increases. Serum separation gel ensures the integrity and stability of serum samples, enabling accurate and reliable test results in veterinary diagnostics. Thus, because of the expansion of veterinary diagnostics, the market is anticipated to increase significantly.

However, the high cost of serum separation gel products, including blood collection tubes containing the gel, can impose a significant financial burden on healthcare facilities, particularly in resource-limited settings or underfunded healthcare systems. Procuring serum separation gel products at high prices may strain budgets allocated for laboratory supplies, diagnostics, and healthcare services, limiting access to essential testing capabilities. Therefore, high-cost constraints are a significant challenge that hampers the growth of market.

Serological tests requiring serum samples experienced a notable upsurge in demand due to the aftermath of the pandemic. Serum separation gel is critical in blood collection tubes for obtaining high-quality serum samples for COVID-19 testing and other diagnostic assays. The heightened demand for diagnostic testing during the pandemic contributed to increased sales of serum separation gel. Thus, the COVID-19 pandemic had a positive impact on the serum separation gel market.

By Product Type Analysis

By product type, the market is categorized into serum separation gel integrated without tube and serum separation gel integrated with tube. The serum separation gel integrated without tube segment covered a 28.9% revenue share in the market in 2023. Serum separation gel is widely used in clinical laboratories for diagnostic testing. It enables the separation of serum from whole blood samples, allowing for the analysis of various biomarkers, enzymes, hormones, and other analytes in the serum.

By End User Analysis

Based on end user, the market is classified into blood bank, hospital, pharmaceutical companies, and others. In 2023, the blood bank segment witnessed 36.6% revenue share in the market. Blood banks routinely perform various blood tests to ensure the safety and compatibility of donated blood products. Serum separation gel is used to obtain high-quality serum samples from donated whole blood, allowing for the screening of infectious diseases, blood typing, antibody testing, and other pre-transfusion testing procedures. The efficient separation of serum using serum separation gel ensures accurate and reliable test results, contributing to the safety of blood transfusions.

By Regional Analysis

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region acquired a 29.3% revenue share in the market. An increasing amount of people in the Asia Pacific region are suffering from chronic illnesses like diabetes, heart disease, and cancer. Urbanization, aging populations, and lifestyle changes are some of the causes contributing to this trend. The Asia Pacific region has a growing awareness of preventive healthcare and early disease detection.

Recent Strategies Deployed in the Market

• Aug-2022: Agilent Technologies, Inc. completed the acquisition of Polymer Standards Service GmbH, a provider of solutions in the field of polymer characterization. Through this acquisition, Agilent expanded its product portfolio and customer offerings, specifically in the chemical and biopharmaceutical sector for the analysis of natural and synthetic polymers such as nucleic acids, proteins, monoclonal antibodies, polysaccharides, and synthetic plastic.
• Mar-2021: Bio-Rad Laboratories, Inc. expanded its partnership with F. Hoffmann-La Roche AG, a Swiss multinational healthcare company. Under this partnership, the companies would provide their joint customers access to Bio-Rad's full range of InteliQ products and Unity QC data management solutions, accompanied by training and support services for customers.
• Dec-2020: Siemens Healthineers AG expanded its joint marketing agreement with Bio-Rad Laboratories, Inc., a life science research and clinical diagnostics company. Under this partnership, Bio-Rad would provide quality control products and Unity Quality Control data management solutions for Siemens Healthineers' Atellica Solution platforms.
• Sep-2020: Bio-Rad Laboratories, Inc. unveiled VIROTROL SARS-CoV-2 and VIROCLEAR SARS-CoV-2 in vitro diagnostics, providing positive and negative quality controls for antibody testing of SARS-CoV-2. These controls are capable of detecting SARS-CoV-2 total IgM and IgG antibodies across various testing methods. Moreover, the U.S. VIROTROL SARS-CoV-2 quality controls serve as independent positive controls to identify the presence of SARS-CoV-2 antibodies in patients.

List of Key Companies Profiled

• Becton, Dickinson, and Company
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Agilent Technologies, Inc.
• Siemens Healthineers AG (Siemens AG)
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Sysmex Corporation
• Charles River Laboratories International, Inc.
• QuidelOrtho Corporation

Global Serum Separation Gel Market Report Segmentation

By Product Type

• Serum Separation Gel Integrated with Tube
• Serum Separation Gel Integrated without Tube

By End User

• Blood Bank
• Hospital
• Pharmaceutical & Companies
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

• 1.1Market Definition
• 1.2Objectives
• 1.3Market Scope
• 1.4Segmentation
  • 1.4.1Global Serum Separation Gel Market, by Product Type
  • 1.4.2Global Serum Separation Gel Market, by End User
  • 1.4.3Global Serum Separation Gel Market, by Geography
• 1.5Methodology for the research

Chapter 2.Market at a Glance

• 2.1Key Highlights

Chapter 3.Market Overview

• 3.1Introduction
  • 3.1.1Overview
    • 3.1.1.1Market Composition and Scenario
• 3.2Key Factors Impacting the Market
  • 3.2.1Market Drivers
  • 3.2.2Market Restraints
  • 3.2.3Market Opportunities
  • 3.2.4Market Challenges
• 3.3Porter's Five Forces Analysis

Chapter 4.Global Serum Separation Gel Market by Product Type

• 4.1Global Serum Separation Gel Integrated with Tube Market by Region
• 4.2Global Serum Separation Gel Integrated without Tube Market by Region

Chapter 5.Global Serum Separation Gel Market by End User

• 5.1Global Blood Bank Market by Region
• 5.2Global Hospital Market by Region
• 5.3Global Pharmaceutical & Companies Market by Region
• 5.4Global Others Market by Region

Chapter 6.Global Serum Separation Gel Market by Region

• 6.1North America Serum Separation Gel Market
  • 6.1.1North America Serum Separation Gel Market by Product Type
    • 6.1.1.1North America Serum Separation Gel Integrated with Tube Market by Region
    • 6.1.1.2North America Serum Separation Gel Integrated without Tube Market by Region
  • 6.1.2North America Serum Separation Gel Market by End User
    • 6.1.2.1North America Blood Bank Market by Country
    • 6.1.2.2North America Hospital Market by Country
    • 6.1.2.3North America Pharmaceutical & Companies Market by Country
    • 6.1.2.4North America Others Market by Country
  • 6.1.3North America Serum Separation Gel Market by Country
    • 6.1.3.1US Serum Separation Gel Market
      • 6.1.3.1.1US Serum Separation Gel Market by Product Type
      • 6.1.3.1.2US Serum Separation Gel Market by End User
    • 6.1.3.2Canada Serum Separation Gel Market
      • 6.1.3.2.1Canada Serum Separation Gel Market by Product Type
      • 6.1.3.2.2Canada Serum Separation Gel Market by End User
    • 6.1.3.3Mexico Serum Separation Gel Market
      • 6.1.3.3.1Mexico Serum Separation Gel Market by Product Type
      • 6.1.3.3.2Mexico Serum Separation Gel Market by End User
    • 6.1.3.4Rest of North America Serum Separation Gel Market
      • 6.1.3.4.1Rest of North America Serum Separation Gel Market by Product Type
      • 6.1.3.4.2Rest of North America Serum Separation Gel Market by End User
• 6.2Europe Serum Separation Gel Market
  • 6.2.1Europe Serum Separation Gel Market by Product Type
    • 6.2.1.1Europe Serum Separation Gel Integrated with Tube Market by Country
    • 6.2.1.2Europe Serum Separation Gel Integrated without Tube Market by Country
  • 6.2.2Europe Serum Separation Gel Market by End User
    • 6.2.2.1Europe Blood Bank Market by Country
    • 6.2.2.2Europe Hospital Market by Country
    • 6.2.2.3Europe Pharmaceutical & Companies Market by Country
    • 6.2.2.4Europe Others Market by Country
  • 6.2.3Europe Serum Separation Gel Market by Country
    • 6.2.3.1Germany Serum Separation Gel Market
      • 6.2.3.1.1Germany Serum Separation Gel Market by Product Type
      • 6.2.3.1.2Germany Serum Separation Gel Market by End User
    • 6.2.3.2UK Serum Separation Gel Market
      • 6.2.3.2.1UK Serum Separation Gel Market by Product Type
      • 6.2.3.2.2UK Serum Separation Gel Market by End User
    • 6.2.3.3France Serum Separation Gel Market
      • 6.2.3.3.1France Serum Separation Gel Market by Product Type
      • 6.2.3.3.2France Serum Separation Gel Market by End User
    • 6.2.3.4Russia Serum Separation Gel Market
      • 6.2.3.4.1Russia Serum Separation Gel Market by Product Type
      • 6.2.3.4.2Russia Serum Separation Gel Market by End User
    • 6.2.3.5Spain Serum Separation Gel Market
      • 6.2.3.5.1Spain Serum Separation Gel Market by Product Type
      • 6.2.3.5.2Spain Serum Separation Gel Market by End User
    • 6.2.3.6Italy Serum Separation Gel Market
      • 6.2.3.6.1Italy Serum Separation Gel Market by Product Type
      • 6.2.3.6.2Italy Serum Separation Gel Market by End User
    • 6.2.3.7Rest of Europe Serum Separation Gel Market
      • 6.2.3.7.1Rest of Europe Serum Separation Gel Market by Product Type
      • 6.2.3.7.2Rest of Europe Serum Separation Gel Market by End User
• 6.3Asia Pacific Serum Separation Gel Market
  • 6.3.1Asia Pacific Serum Separation Gel Market by Product Type
    • 6.3.1.1Asia Pacific Serum Separation Gel Integrated with Tube Market by Country
    • 6.3.1.2Asia Pacific Serum Separation Gel Integrated without Tube Market by Country
  • 6.3.2Asia Pacific Serum Separation Gel Market by End User
    • 6.3.2.1Asia Pacific Blood Bank Market by Country
    • 6.3.2.2Asia Pacific Hospital Market by Country
    • 6.3.2.3Asia Pacific Pharmaceutical & Companies Market by Country
    • 6.3.2.4Asia Pacific Others Market by Country
  • 6.3.3Asia Pacific Serum Separation Gel Market by Country
    • 6.3.3.1China Serum Separation Gel Market
      • 6.3.3.1.1China Serum Separation Gel Market by Product Type
      • 6.3.3.1.2China Serum Separation Gel Market by End User
    • 6.3.3.2Japan Serum Separation Gel Market
      • 6.3.3.2.1Japan Serum Separation Gel Market by Product Type
      • 6.3.3.2.2Japan Serum Separation Gel Market by End User
    • 6.3.3.3India Serum Separation Gel Market
      • 6.3.3.3.1India Serum Separation Gel Market by Product Type
      • 6.3.3.3.2India Serum Separation Gel Market by End User
    • 6.3.3.4South Korea Serum Separation Gel Market
      • 6.3.3.4.1South Korea Serum Separation Gel Market by Product Type
      • 6.3.3.4.2South Korea Serum Separation Gel Market by End User
    • 6.3.3.5Singapore Serum Separation Gel Market
      • 6.3.3.5.1Singapore Serum Separation Gel Market by Product Type
      • 6.3.3.5.2Singapore Serum Separation Gel Market by End User
    • 6.3.3.6Malaysia Serum Separation Gel Market
      • 6.3.3.6.1Malaysia Serum Separation Gel Market by Product Type
      • 6.3.3.6.2Malaysia Serum Separation Gel Market by End User
    • 6.3.3.7Rest of Asia Pacific Serum Separation Gel Market
      • 6.3.3.7.1Rest of Asia Pacific Serum Separation Gel Market by Product Type
      • 6.3.3.7.2Rest of Asia Pacific Serum Separation Gel Market by End User
• 6.4LAMEA Serum Separation Gel Market
  • 6.4.1LAMEA Serum Separation Gel Market by Product Type
    • 6.4.1.1LAMEA Serum Separation Gel Integrated with Tube Market by Country
    • 6.4.1.2LAMEA Serum Separation Gel Integrated without Tube Market by Country
  • 6.4.2LAMEA Serum Separation Gel Market by End User
    • 6.4.2.1LAMEA Blood Bank Market by Country
    • 6.4.2.2LAMEA Hospital Market by Country
    • 6.4.2.3LAMEA Pharmaceutical & Companies Market by Country
    • 6.4.2.4LAMEA Others Market by Country
  • 6.4.3LAMEA Serum Separation Gel Market by Country
    • 6.4.3.1Brazil Serum Separation Gel Market
      • 6.4.3.1.1Brazil Serum Separation Gel Market by Product Type
      • 6.4.3.1.2Brazil Serum Separation Gel Market by End User
    • 6.4.3.2Argentina Serum Separation Gel Market
      • 6.4.3.2.1Argentina Serum Separation Gel Market by Product Type
      • 6.4.3.2.2Argentina Serum Separation Gel Market by End User
    • 6.4.3.3UAE Serum Separation Gel Market
      • 6.4.3.3.1UAE Serum Separation Gel Market by Product Type
      • 6.4.3.3.2UAE Serum Separation Gel Market by End User
    • 6.4.3.4Saudi Arabia Serum Separation Gel Market
      • 6.4.3.4.1Saudi Arabia Serum Separation Gel Market by Product Type
      • 6.4.3.4.2Saudi Arabia Serum Separation Gel Market by End User
    • 6.4.3.5South Africa Serum Separation Gel Market
      • 6.4.3.5.1South Africa Serum Separation Gel Market by Product Type
      • 6.4.3.5.2South Africa Serum Separation Gel Market by End User
    • 6.4.3.6Nigeria Serum Separation Gel Market
      • 6.4.3.6.1Nigeria Serum Separation Gel Market by Product Type
      • 6.4.3.6.2Nigeria Serum Separation Gel Market by End User
    • 6.4.3.7Rest of LAMEA Serum Separation Gel Market
      • 6.4.3.7.1Rest of LAMEA Serum Separation Gel Market by Product Type
      • 6.4.3.7.2Rest of LAMEA Serum Separation Gel Market by End User

Chapter 7.Company Profiles

• 7.1Becton, Dickinson, and Company
  • 7.1.1Company Overview
  • 7.1.2Financial Analysis
  • 7.1.3Segmental and Regional Analysis
  • 7.1.4Research & Development Expense
  • 7.1.5SWOT Analysis
• 7.2F. Hoffmann-La Roche Ltd.
  • 7.2.1Company Overview
  • 7.2.2Financial Analysis
  • 7.2.3Segmental and Regional Analysis
  • 7.2.4Research & Development Expense
  • 7.2.5SWOT Analysis
• 7.3Abbott Laboratories
  • 7.3.1Company Overview
  • 7.3.2Financial Analysis
  • 7.3.3Segmental and Regional Analysis
  • 7.3.4Research & Development Expense
  • 7.3.5SWOT Analysis
• 7.4Agilent Technologies, Inc.
  • 7.4.1Company Overview
  • 7.4.2Financial Analysis
  • 7.4.3Segmental and Regional Analysis
  • 7.4.4Research & Development Expense
  • 7.4.5Recent strategies and developments:
    • 7.4.5.1Acquisition and Mergers:
  • 7.4.6SWOT Analysis
• 7.5Siemens Healthineers AG (Siemens AG)
  • 7.5.1Company Overview
  • 7.5.2Financial Analysis
  • 7.5.3Segmental and Regional Analysis
  • 7.5.4Research & Development Expense
  • 7.5.5Recent strategies and developments:
    • 7.5.5.1Partnerships, Collaborations, and Agreements:
  • 7.5.6SWOT Analysis
• 7.6Bio-Rad laboratories, Inc.
  • 7.6.1Company Overview
  • 7.6.2Financial Analysis
  • 7.6.3Segmental and Regional Analysis
  • 7.6.4Research & Development Expenses
  • 7.6.5Recent strategies and developments:
    • 7.6.5.1Partnerships, Collaborations, and Agreements:
    • 7.6.5.2Product Launches and Product Expansions:
  • 7.6.6SWOT Analysis
• 7.7Danaher Corporation
  • 7.7.1Company Overview
  • 7.7.2Financial Analysis
  • 7.7.3Segmental and Regional Analysis
  • 7.7.4Research & Development Expense
  • 7.7.5SWOT Analysis
• 7.8Sysmex Corporation
  • 7.8.1Company Overview
  • 7.8.2Financial Analysis
  • 7.8.3Regional Analysis
  • 7.8.4Research & Development Expense
  • 7.8.5SWOT Analysis
• 7.9Charles River Laboratories International, Inc.
  • 7.9.1Company Overview
  • 7.9.2Financial Analysis
  • 7.9.3Segmental and Regional Analysis
  • 7.9.4SWOT Analysis
• 7.10.QuidelOrtho Corporation
  • 7.10.1Company Overview
  • 7.10.2Financial Analysis
  • 7.10.3Regional Analysis
  • 7.10.4Research & Development Expense
  • 7.10.5SWOT Analysis

Chapter 8.Winning Imperatives of Serum Separation Gel Market